STIA
WINT

Stone Toro Investment Advisers’s Windtree Therapeutics Inc WINT Stock Holding History

Stone Toro Investment Advisers’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,643
Closed -$80K – 145
2014
Q1 		$80K Buy
+2,643
New +$88.9K 0.11% 133

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Stone Toro Investment Advisers's WINT Position: Q2 2014 in Review

Stone Toro Investment Advisers sold out of Windtree Therapeutics Inc (WINT) in Q2 2014, closing a stake of 2,643 shares — an estimated $80K sold.

Stone Toro Investment Advisers first reported a position in WINT in Q1 2014 and held it in 1 quarter. The position peaked at $80K in Q1 2014. 67 funds tracked by Wall St. Rank hold WINT as of Q2 2014.

  • Stone Toro Investment Advisers reported no remaining Windtree Therapeutics Inc position as of Q2 2014 after selling out during the quarter.
  • Stone Toro Investment Advisers sold 2,643 Windtree Therapeutics Inc shares in Q2 2014, an estimated $80K.
  • Stone Toro Investment Advisers first reported a position in Windtree Therapeutics Inc in Q1 2014 and held it in 1 quarter.
  • Stone Toro Investment Advisers's Windtree Therapeutics Inc position peaked at $80K in Q1 2014.
  • 67 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2014.

Based on Stone Toro Investment Advisers's 13F filing for Q2 2014, filed 28 Jul 2014.